What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing other specified and related medical disorders in patients across various demographics, including children and geriatric individuals, with consideration of past medical history and comorbid conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Strengths and Weaknesses of DSM-5-TR and ICD-11 for Other Specified and Related Medical Disorders

Both DSM-5-TR and ICD-11 have complementary strengths: DSM-5-TR provides categorical clarity essential for insurance reimbursement and treatment justification, while ICD-11 offers superior clinical utility through dimensional symptom assessment across six domains (positive, negative, depressive, manic, psychomotor, cognitive) rated on a 4-point scale, which is particularly valuable when medical conditions produce partial or atypical presentations. 1, 2

Strengths of ICD-11

Enhanced Clinical Utility

  • ICD-11's dimensional approach provides more nuanced symptom profiles that inform treatment planning, particularly for psychotherapy selection and intensity, especially in patients with trauma or substance abuse histories 1
  • Field studies with 928 clinicians demonstrated that 82.5% to 83.9% rated ICD-11 as quite or extremely easy to use, accurate, clear, and understandable—superior to ICD-10 2, 3
  • The dimensional profiles allow rating symptom severity across all six domains at each assessment, capturing nuances that categorical diagnosis misses when medical conditions complicate presentations 2

Structural Improvements

  • ICD-11 expanded from 11 to 21 disorder groupings in the mental, behavioral, and neurodevelopmental disorders chapter, providing more comprehensive classification 4, 3
  • The system eliminated the separate disorder grouping for childhood and adolescence onset, highlighting developmental continuity across the lifespan 4
  • ICD-11 conceptualizes conditions like catatonia as independent disorders with explicit differential guidance, rather than subtypes of other conditions 3

Global Applicability

  • The WHO and American Psychiatric Association collaborated to ensure better alignment between DSM-5 and ICD-11, while ICD-11 retained distinct conceptual orientations emphasizing dimensional assessment and global applicability 1, 5

Strengths of DSM-5-TR

Practical Clinical Framework

  • DSM-5-TR provides a categorical framework that facilitates insurance reimbursement and treatment justification in most healthcare systems 2
  • The system maintains clear categorical distinctions between substance/medically-induced and primary disorders, which is critical when evaluating patients with complex medical histories on multiple medications 2
  • DSM-5-TR introduced a single set of criteria for conditions like catatonia across all psychiatric disorders, providing consistency 3

Harmonization Efforts

  • Much of the DSM-5 decision-making was driven by a desire to ensure better alignment with ICD-11, bringing the field closer to a singular, cohesive nosology 5

Shared Weaknesses of Both Systems

Lack of Biological Validation

  • Neither DSM-5-TR nor ICD-11 has biological validation, resulting in biologically heterogeneous groups within the same diagnostic category 3
  • Both systems classify mental phenomena based on self-reported or clinically observable symptoms rather than underlying pathophysiology 3
  • Arbitrary boundaries between diagnostic categories limit reliability and validity 3

Categorical Core Limitations

  • Both systems remain categorical at their core despite efforts toward dimensionality, with changes from previous versions being relatively modest 3
  • Large within-category heterogeneity, comorbidity, and difficulties in representing subthreshold symptomatology persist 4

Validity Concerns with Structured Interviews

  • Standardized diagnostic interviews cannot make specific differential diagnoses but rather catch unspecific syndromes, partly due to vague wording, definition, and understanding of underlying criteria 6
  • This problem is magnified when somatic comorbidity is present, which is particularly relevant for "other specified and related medical disorders" 6

Specific Limitations for Special Populations

Geriatric Patients

  • Both systems lack specific guidance for distinguishing conditions like catatonia from delirium in elderly patients, despite this being a critical clinical challenge 3
  • The overlap between psychiatric features and age-related changes is not adequately addressed 3

Pediatric Considerations

  • While ICD-11 eliminated separate childhood disorder groupings to emphasize developmental continuity, neither system provides adequate guidance for distinguishing developmentally appropriate behaviors from pathology in children 4

Patients with Medical Comorbidities

  • ICD-11's dimensional framework provides crucial flexibility when medical conditions produce partial or atypical presentations, allowing clinicians to document symptom severity across all six domains 2
  • However, neither system adequately addresses how to differentiate primary psychiatric disorders from those secondary to medical conditions beyond general exclusion criteria 2

Optimal Diagnostic Strategy

Combined Approach

  • When evaluating disorders potentially secondary to medical conditions, use ICD-11's dimensional framework to document symptom severity across all six domains at each assessment, while maintaining DSM-5-TR's categorical distinction between substance/medically-induced and primary disorders 2
  • Use structured diagnostic interviews (such as SCID-5 or MINI 7.0) rather than unstructured clinical assessment to reduce diagnostic bias, though recognize their limitations with somatic comorbidity 1, 6

Documentation Requirements

  • Create detailed life charts documenting the longitudinal course of symptoms to track whether presentations evolve over time 1
  • Document response to specific treatments versus treatment of underlying medical conditions to help differentiate primary from secondary presentations 2
  • Gather collateral information from family members and other observers, as patient insight may be limited during acute episodes 1

Critical Pitfalls to Avoid

  • Do not rely solely on categorical diagnosis when medical conditions are present—the dimensional approach captures critical nuances that categorical systems miss 2
  • Avoid assuming that standardized interviews provide definitive differential diagnoses in medically complex patients, as they are prone to false positives when somatic symptoms overlap with psychiatric criteria 6
  • Do not neglect longitudinal reassessment, as diagnoses may evolve over time and initial presentations may not reflect the ultimate diagnostic picture 1
  • Be cautious about applying either system in geriatric populations without additional clinical judgment regarding delirium and age-related changes 3

References

Guideline

Brief Psychotic Disorder Diagnostic Criteria Evolution

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Considerations for Bipolar Disorder Due to Another Medical Condition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Systems for Catatonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The DSM-5: Classification and criteria changes.

World psychiatry : official journal of the World Psychiatric Association (WPA), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.